The Texas Constitution, Article III, Section 67, creates CPRIT and charges the Institute with distributing up to $6 billion in general obligation bonds for research to cure and mitigate cancer. CPRIT’s governing statute, Texas Health and Safety Code Chapter 102, guides the agency’s work honoring that commitment to the citizens of Texas.
CPRIT’s statutory mandate is to create and expedite innovation in cancer research and enhance the potential for breakthroughs in cancer prevention and cures; attract, create, and expand research capabilities of institutions of higher education and other public and private entities to promote a substantial increase in cancer research and create high-quality new jobs in Texas; and develop and implement the Texas Cancer Plan.
The Oversight Committee is the Institute’s governing body. In addition to establishing priorities for each of CPRIT’s three program areas, the Oversight Committee approves grant awards and adopts policies necessary for its meetings, awarding grants, and management of the agency.
The Governor, Lieutenant Governor, and the Speaker of the House each appoint three private citizens to serve as Oversight Committee members for six-year terms. At least one member appointed by each of the officers must be a physician or scientist with experience in oncology or public health.
Texas is a world-class leader in cancer research and prevention efforts. CPRIT’s investments through its Academic Research, Product Development Research and Prevention Programs connect universities, researchers, physicians, companies, hospitals, and clinics across Texas to form a critical ecosystem of distinguished cancer-fighting talent. CPRIT is proud to be a part of this connectivity. Projects funded by CPRIT create high quality jobs, support critical lab infrastructure assets, and help thousands of cancer patients extend their lives.
1,576
Grants Awarded for Academic Research, Product Development Research and Prevention Projects
$2.64 Billion
Committed Grant Funds
115
Grant Recipient Institutions, Organizations, and Companies
Over the past decade, Texas has emerged as a cancer research powerhouse. CPRIT-funded researchers are discovering new insights about cancer and translating those discoveries into practical advances in cancer prevention, diagnosis, treatment, and survivorship. Investing in cancer research has led to life-saving treatments and new prevention strategies, increasing the prominence and stature of Texas in the fight against cancer. In addition to the investments in recruitment, training, and core facilities, CPRIT’s academic research program is committed to funding projects in critical but underfunded areas of cancer research.
CPRIT’s product development research program funds cancer research and development activities at Texas-based companies, accelerating promising research discoveries through the crucial preliminary stages of regulatory testing. CPRIT’s investment is critically important to startup companies because it is available when private capital is most difficult to obtain. CPRIT bridges this “valley of death” between public and private funding with working capital necessary for companies to complete early-stage development activities and secure funding from outside sources.
Half of all cancers are preventable. Reducing the number of Texans dying from cancer requires making scientifically proven prevention interventions widely available. CPRIT’s prevention program invests in evidence-based, culturally appropriate cancer prevention projects in communities across the state, with priority given to medically underserved areas and populations disproportionally affected by cancer. CPRIT’ s prevention grant awards increase the availability of cancer prevention education, vaccinations, screenings, survivorship and other services - saving lives and reducing the burden of cancer for Texans. The map below shows all prevention projects active in FY 2020 by county, legislative districts, and public health regions. Click on the red pins for Prevention Grantee highlights from around the state.
The interactive map is only available on larger width devices. Try turning your device horizontally (landscape mode)
Overlay Selection
County
Projects:
In addition to county-specific grants, CPRIT awarded 10 statewide Dissemination projects in FY 2020.
In carrying out its responsibility to develop and implement CPRIT’s programs and policies, the Oversight Committee relies upon the input from committees of experts. These advisory committees provide advice on specific cancer-related topics, including the role of higher education in cancer research, childhood cancer, product development, clinical trials, and prevention activities.
Advisory Committee on Childhood Cancers
Product Development Advisory Committee
| Legislative Appropriations | $ 297,575,972 |
| License, Fees, and Permits | 956,426 |
| Interest Income | 553 |
| Sales of Goods and Services | 20 |
| Other | 33,136 |
| Total Revenues | $298,566,107 |
| Salaries and Wages | $ 3,940,309 |
| Other Personnel Costs | 850,066 |
| Professional Fees and Services | 10,471,487 |
| Travel | 50,332 |
| Materials and Supplies | 367,326 |
| Communication and Utilities | 213,289 |
| Repairs and Maintenance | 4,134 |
| Rentals and Leases | 18,580 |
| Printing and Reproduction | 510 |
| Grant Payments | 204,714,882 |
| Other Operating Expenditures | 418,304 |
| Capital Outlay | 49,094 |
| Total Expenses | $221,098,313 |
FY2020 Financial Audit Report (PDF)
CPRIT’s executive management is responsible for establishing and maintaining adequate internal control over financial reporting and compliance with applicable laws, regulations, contracts, and grant agreements, as well as other matters.
McConnell & Jones LLP, a certified public accounting firm, audited CPRIT’s financial statements for the year ending August 31, 2020, ascertaining that the statements “present fairly, in all material respects, the respective financial position of the governmental activities and governmental fund information of CPRIT as of August 31, 2020, and the respective changes in financial position for the year then ended in accordance with U.S. GAAP.”
As part of the audit report on the financial statements, McConnell & Jones LLP reviewed CPRIT’s internal control over financial reporting and performed tests of CPRIT’s compliance with certain provisions of laws, regulations, contracts, and grant agreements to ensure that the statements are free from material misstatements. McConnell & Jones LLP identified no instance of noncompliance or other matter that required reporting under Government Auditing Standards.
